SCHEMBL171969

SCHEMBL171969

O=C1CCCC(=O)C1Br

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3796373 0.93 CA1 (0.43)
SCHEMBL13125935 0.90 KMT2A (0.46)
SCHEMBL1851994 0.86
SCHEMBL9239028 0.75
SCHEMBL2342739 0.69
SCHEMBL918055 0.67
SCHEMBL21495046 0.67
SCHEMBL280398 0.67
SCHEMBL10882169 0.67
SCHEMBL7549489 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 165 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115677559-B One-step synthesis method of ondansetron intermediate tetrahydrocarbazolone 常州兰陵制药有限公司 2024-04-16 CN claimed
CN-115677559-A One-step synthesis method of ondansetron intermediate tetrahydrocarbazolone 常州兰陵制药有限公司 2023-02-03 CN claimed
CN-111689927-A Piperazinyl tetrahydrobenzothiazole oxime ether derivative and application thereof 南开大学 2020-09-22 CN claimed
CN-111662280-A Piperidinyl tetrahydrobenzothiazole oxime ether derivative and application thereof 南开大学 2020-09-15 CN claimed
CN-105777773-A Thiophene[2,3-b]quinoline derivative and synthetic method and application thereof 浙江师范大学 2016-07-20 CN claimed
US-20260034093-A1 MULTICYCLIC COMPOUNDS AND METHODS OF USE THEREOF SUMITOMO PHARMA AMERICA, INC. (US) 2026-02-05 US disclosed
EP-4626423-A1 CDK INHIBITORS AND METHODS AND USE THEREOF Relay Therapeutics, Inc. (US) 2025-10-08 EP disclosed
US-20240358675-A1 MULTICYCLIC COMPOUNDS AND METHODS OF USE THEREOF SUMITOMO PHARMA AMERICA, INC. (US) 2024-10-31 US disclosed
CN-118165002-A Polycyclic compounds and methods of use thereof 桑诺维恩药品公司 2024-06-11 CN disclosed
WO-2024119122-A1 CDK INHIBITORS AND METHODS AND USE THEREOF RELAY THERAPEUTICS, INC. (US) 2024-06-06 WO disclosed
CN-115677559-B One-step synthesis method of ondansetron intermediate tetrahydrocarbazolone 常州兰陵制药有限公司 2024-04-16 CN disclosed
CN-115677559-B One-step synthesis method of ondansetron intermediate tetrahydrocarbazolone 常州兰陵制药有限公司 2024-04-16 CN disclosed
EP-0843681-A1 HETEROCYCLE-FUSED THIAZOLE DERIVATIVES YUNGJIN PHARMACEUTICAL CO., LTD. (KR) 1998-05-27 EP disclosed
CN-1179162-A fused heterocyclic thiazole derivatives YUNGJIN PHARMACEUTICLA CO LTD (KR) 1998-04-15 CN disclosed
WO-1997003076-A1 HETEROCYCLE-FUSED THIAZOLE DERIVATIVES YUNGJIN PHARMACEUTICAL CO., LTD. (KR) 1997-01-30 WO disclosed
US-4257957-A Methyl-tris-(4-hydroxycoumarin)silane GENERAL ELECTRIC COMPANY (US) 1981-03-24 US disclosed
US-4238401-A ALKANOL, HALOSILANE, 1,3-DICARBONYL CYCLIC COMPOUND, VULCANIZATION AGENTS GENERAL ELECTRIC COMPANY (US) 1980-12-09 US disclosed
US-4210596-A Silyl ethers of 1,3-dicarbonyl cyclic compounds GENERAL ELECTRIC COMPANY (US) 1980-07-01 US disclosed
US-3954984-A ANTISECRETRETORY AGENTS, CENTRAL NERVOUS SYSTEM DEPRESSANTS RICHARDSON-MERRELL INC. (US) 1976-05-04 US disclosed
US-3931171-A FROM A 1,3-DIOXINONE-(4) AND AN ISOCYANATE BAYER AKTIENGESELLSCHAFT (DT) 1976-01-06 US disclosed